A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Fred Hutchinson Cancer Center
University of Palermo
Maastricht University Medical Center
Ohio State University Comprehensive Cancer Center
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Massachusetts General Hospital
University Hospital Bispebjerg and Frederiksberg
University of Miami
Maastricht University Medical Center
University of California, Irvine
Technische Universität Dresden
Massachusetts General Hospital
Duke University
Maastricht University Medical Center
Centre Hospitalier Universitaire de Saint Etienne
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Case Comprehensive Cancer Center
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
University of Oklahoma
M.D. Anderson Cancer Center
City of Hope Medical Center
Zealand University Hospital